New Chapter 11 Filing - Orexigen Therapeutics Inc.

Mar 12, 2018

∙ Paid

Orexigen Therapeutics Inc.

3/12/18

Orexigen Therapeutics is a publicly-traded ($OREX) biopharmaceutical company with one FDA-approved product - "Contrave" - an adjunct to a reduced-calorie diet and exercise for chronic weight management in certain eligible adults. (Before we continue, please take a minute to appreciate the exquisite creativity these folk…

Keep reading with a 7-day free trial

Subscribe to PETITION to keep reading this post and get 7 days of free access to the full post archives.